In this analysis of ILA reported in a prevalence LDCT screening round, 2.5% of cases had mention of ILA in their CT report and 0.8% of cases were deemed clinically significant needing referral to the ILD service. This evidence concerns the gene TNFRSF9 and interstitial lung disease.